IP Library Granted Patent US 7,628,789
Granted Patent B2
US 7,628,789 · App. 11/460,860 · Granted Dec 8, 2009

Selective lung tissue ablation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,628,789
App. No.
11/460,860
Granted
Dec 8, 2009
Kind
B2
Abstract

Medical methods and systems are provided for effecting lung volume reduction by selectively ablating segments of lung tissue.

Claims (18)

1. A method for selectively ablating a treatment site subject to collateral ventilation in a lung, said method comprising:

testing a patient to identify a treatment site in a lung which is subject to collateral ventilation in the lung;

advancing a treatment apparatus through an airway toward the identified treatment site in the lung; and

delivering energy through the treatment apparatus to heat or cool the treatment site to a level which destroys tissue in the site while protecting adjacent regions in the lung and surrounding tissue from thermal damage, wherein the exchanged energy induces tissue necrosis followed by collapse of the treatment site.

2. A method as in claim 1 , wherein the treated tissue is raised to a temperature in the range from 40° C. to 95° C.

3. A method as in claim 1 , wherein the delivered energy comprises radio frequency, alternating current, microwave, ultrasound, coherent light, incoherent light, radioisotopes, or any combination of these.

4. A method as in claim 1 , wherein the delivered energy comprises thermal energy generated from a resistive coil or a hot fluid element.

5. A method as in claim 1 , further comprising advancing at least one additional treatment apparatus toward the treatment site in the lung and delivering energy to the treatment site through at least two treatment apparatuses.

6. A method as in claim 1 , further comprising ventilating the patient's other lung.

7. A method as in claim 6 , further comprising ventilating untreated region(s) of the lung adjacent to the treated region.

8. A method as in claim 1 , further comprising collapsing the lung containing the site under treatment prior to heating a treatment site.

9. A method as in claim 1 , further comprising controlling pressure and temperature simultaneously in the treatment site and in the one or more untreated regions adjacent the treatment site so that thermal damage to the non-targeted sites is minimized.

10. A method as in claim 1 , wherein the treatment site comprises an entire lobe of the lung.

11. A method as in claim 1 , wherein the treatment site comprises a segment of a lobe of the lung.

12. A method as in claim 1 , wherein the treatment site comprises a subsegment of a lobe of the lung.

13. A method as in claim 1 , further comprising introducing an electrically or thermally conducting fluid into the treatment site to improve energy distribution.

14. A method as in claim 13 , further comprising deploying isolation barriers to inhibit the conductive fluid from migrating from the treatment site.

15. A method as in claim 1 , further comprising monitoring the temperature within the treatment site and controlling the energy exchange to maintain a temperature within a desired range.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 4, 2026
From: CANADIAN IMPERIAL BANK OF COMMERCE
To: PULMONX CORPORATION
Reel/Frame 075028/0274 →
SECURITY INTEREST Recorded Mar 2, 2026
From: PULMONX CORPORATION
To: PERCEPTIVE CREDIT HOLDINGS V, LP, AS ADMINISTRATIVE AGENT
Reel/Frame 075012/0453 →
SECURITY INTEREST Recorded Jan 27, 2026
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 074570/0001 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: BOSTON SCIENTIFIC CORPORATION
To: PULMONX CORPORATION
Reel/Frame 053953/0548 →
RELEASE OF SECURITY INTEREST Recorded Sep 30, 2020
From: OXFORD FINANCE LLC, AS COLLATERAL AGENT
To: PULMONX CORPORATION
Reel/Frame 053952/0044 →
SECURITY INTEREST Recorded Mar 2, 2020
From: PULMONX CORPORATION
To: CANADIAN IMPERIAL BANK OF COMMERCE
Reel/Frame 052916/0213 →
MERGER Recorded Apr 23, 2019
From: PULMONX
To: PULMONX CORPORATION
Reel/Frame 048964/0563 →
SECURITY INTEREST Recorded Jul 26, 2017
From: PULMONX CORPORATION
To: BOSTON SCIENTIFIC CORPORATION
Reel/Frame 043349/0725 →
SECURITY INTEREST Recorded May 15, 2017
From: PULMONX CORPORATION
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 042466/0349 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 7, 2006
From: SOLTESZ, PETER P.; ALJURI, NIKOLAI; NAIR, AJIT
To: PULMONX
Reel/Frame 018492/0159 →